“ Cupris Health – The Doctor in your pocket”

“ Cupris Health – The Doctor in your pocket”

At the 2015 AXA PPP Health Tech & You awards, the winner in the category for Signs & Symptoms and also recently identified as number 7 in the Top 20 Digital Health Startups to watch was London based Cupris Health.

Cupris Health turns smartphones into medical devices using patent-pending clip-on attachments. The devices connect to their web-based service that allows clinical information to be securely transmitted between healthcare practitioners and their patients. They make healthcare provision faster, cheaper and more accessible. The current product is a smartphone connected otoscope that enables users to take still and video images of their inner-ear to share with healthcare professionals.  The inspiration came from Julian Hamann, an NHS ear, nose and throat surgeon to help reduce unnecessary ENT-related patient consultations.

The device captures the image and then can be sent, along with notes to a clinician allowing the remote diagnosis of ear conditions. Their cloud based system also enables doctors and patients to monitor conditions over time which in turn cuts down the number of clinical appointments necessary and it also makes it far easier for doctors to explain the symptoms to their patients.  There is a huge potential for using their technology in areas where access to healthcare is limited as well as for the 90% of children who suffer from ear infections before the age of six and many of these then develop chronic  conditions. Medical training is also a huge potential application.

Cupris Health have also just been shortlisted in the Value and Improvement in Telehealth category at the 2015 Health Service Journal (HSJ) Value in Healthcare Awards, to be held on 22 September at the Grosvenor House Hotel, London.

The HSJ Value in Healthcare Awards has had a record breaking year for entries, more organisations than ever before demonstrated that they are striving to improve value and efficiency in healthcare. From 532 entries, 140 organisations have been judged to be leading the way in this increasingly important area.

The shortlisted organisations will now complete presentations and interviews to a specific judging panel made up of senior and influential figures from the health sector. These include:

  • Charles Alessi, Chairman, National Association of Primary Care
  • Professor Jonathan Kay, Clinical Informatics Director, NHS England
  • Michael MacDonnell, Head of Strategy, NHS England
  • Robert Knott, National Director NHS Procurement, Department of Health

The HSJ Value in Healthcare Awards seeks to recognise and reward outstanding efficiency and improvement by the NHS. The awards continue to recognise excellent use of resources. But they also seek out examples of demonstrable improvement in outcomes, both within back office functions and clinical initiatives.

The awards will be handed out at an inspirational ceremony on 22 September 2015 at Grosvenor House Hotel, London.

Cupris Health CEO Mike Pallett comments “We believe that our software platform and smartphone-connected medical devices can significantly improve the delivery of healthcare in the NHS. We have worked closely with GPs, surgeons, nurses, carers and patients to design a product that fits precisely with their needs. It is extremely important for us as a company to receive this external validation of the value of our innovation, and to gain the exposure that comes with being shortlisted for this prestigious award.”

We feel this is an amazing use of mHealth and clearly demonstrates how a simple but highly effective concept can really benefits the lives of patients and help reduce the NHS burden.

THE AUTHOR

Paul Budd

Co-Founder and Business Development Director

Paul is an experienced sales & marketing leader within the healthcare sector and is a Co-Founder of Salus Digital. He is a Digital Health enthusiast with a passion for extending the reach of technology to improve patient’s lives and reduce the strain on healthcare services.

LinkedIn | More articles by Paul Budd

COMMENTS